CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, the leading sirtuin therapeutics company, announced today that Christoph Westphal, MD, PhD, co-founder and CEO of Sirtris, will be presenting at the Endeavor Boston Tour 2006. Dr. Westphal will discuss the Company’s strategy for discovering and developing first in class therapeutics that modulate sirtuins, and hence treat diseases of aging such as diabetes.
